A three-year clinical study found that Hoya Vision Care’s MiyoSmart spectacle lens was effective in the continued slowing of myopia progression.

The study was conducted by the Centre for Myopia Research at the Hong Kong Polytechnic University and published in the British Journal of Ophthalmology.

It followed a two-study and was conducted on 120 children, which included 65 from the original group and 55 children who moved from using a single vision lens for two years to MiyoSmart in the third year.

Griff Altmann, chief technology officer at Hoya Vision Care, said: ‘The results of the three-year follow-up study on the MiyoSmart spectacle lens are very positive providing evidence that the lens continues to slow myopia progression in children, including the impressive results when switching from a single vision lens.’

Results at the end of the third year showed slowing of progression over time was sustained in children from the original group.

In the group that moved from regular single vision lenses to MiyoSmart, a significant and immediate slowing was found in the progression of myopia.

The original two-year study found the effectiveness of the lens in slowing down the progression of myopia was on average by 60% in children ages eight to 13.